We further performed immunohistochemical detection of P-Nrf2 and HNF4, which activation was predicted on upstream regulator analysis by IPA, and in support, the results demonstrated elevation of P-Nrf2 and HNF4A in nuclei and cytoplasm HCC cells (Figure 2C). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.